Biotech · Private company
Integrium
Track this companyFree. Adds Integrium to your Dealase workspace and tells you when its record changes.
Clinical trials130 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials13
- Safety And Tolerability Of Subcutaneous MANP In Difficult To Control/Resistant Hypertensive SubjectsPHASE1 · COMPLETED · started Dec 20, 2021ClinicalTrials.gov NCT05247528 · fetched Nov 12, 2026
- A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes MellitusPHASE3 · TERMINATED · started Mar 16, 2021ClinicalTrials.gov NCT04754334 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes MellitusPHASE3 · TERMINATED · started Dec 15, 2020ClinicalTrials.gov NCT04606576 · fetched Nov 12, 2026
- A Study to Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH)PHASE2 · COMPLETED · started Nov 24, 2020ClinicalTrials.gov NCT04618744 · fetched Nov 12, 2026
- A Study to Compare ORMD-0801 Once Daily to ORMD-0801 Three Times Daily in Subjects With Type 1 DiabetesPHASE2 · COMPLETED · started Oct 17, 2019ClinicalTrials.gov NCT04150107 · fetched Nov 12, 2026
- Safety and Tolerability of NTRX-07 in Healthy VolunteersPHASE1 · COMPLETED · started Oct 10, 2019ClinicalTrials.gov NCT04375436 · fetched Nov 12, 2026
- A Phase 1b Study of STMC-103H in Multi-Sensitized Allergic Subjects Who Are Otherwise HealthyPHASE1 · UNKNOWN · started Oct 10, 2018ClinicalTrials.gov NCT03819881 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes MellitusPHASE2 · COMPLETED · started May 29, 2018ClinicalTrials.gov NCT03467932 · fetched Nov 12, 2026
- Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic RhinitisPHASE1_PHASE2 · COMPLETED · started Sep 19, 2017ClinicalTrials.gov NCT03290248 · fetched Nov 12, 2026
- Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes MellitusPHASE2 · COMPLETED · started Jul 27, 2015ClinicalTrials.gov NCT02496000 · fetched Nov 12, 2026
- A Study to Evaluate the Effects of LCI699 on Cortisol in Participants With HypertensionPHASE2 · COMPLETED · started Jan 14, 2009ClinicalTrials.gov NCT00817414 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of LCI699 Compared to Placebo in Participants With Resistant HypertensionPHASE2 · COMPLETED · started Dec 22, 2008ClinicalTrials.gov NCT00817635 · fetched Nov 12, 2026
- A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood PressurePHASE4 · COMPLETED · started Nov 1, 2008ClinicalTrials.gov NCT00791258 · fetched Nov 12, 2026